JPS6341910B2 - - Google Patents

Info

Publication number
JPS6341910B2
JPS6341910B2 JP52135591A JP13559177A JPS6341910B2 JP S6341910 B2 JPS6341910 B2 JP S6341910B2 JP 52135591 A JP52135591 A JP 52135591A JP 13559177 A JP13559177 A JP 13559177A JP S6341910 B2 JPS6341910 B2 JP S6341910B2
Authority
JP
Japan
Prior art keywords
propoxy
phenoxymethyl
piperidino
hydroxy
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52135591A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5363385A (en
Inventor
Kanpe Borufuganku
Gunaaru Furiibe Uarutaa
Biideman Furitsutsu
Shuhoonaa Gisuberuto
Baruchu Borufuganku
Deiitoman Kaaru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762651574 external-priority patent/DE2651574A1/de
Priority claimed from DE19772737630 external-priority patent/DE2737630A1/de
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of JPS5363385A publication Critical patent/JPS5363385A/ja
Publication of JPS6341910B2 publication Critical patent/JPS6341910B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP13559177A 1976-11-12 1977-11-11 Novel aminopropanole derivative process for preparing same and medicine having vasodilating and betaaacceptor interupiing efect Granted JPS5363385A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762651574 DE2651574A1 (de) 1976-11-12 1976-11-12 Ein neues aminopropanol-derivat und verfahren zu dessen herstellung
DE19772737630 DE2737630A1 (de) 1977-08-20 1977-08-20 Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
JPS5363385A JPS5363385A (en) 1978-06-06
JPS6341910B2 true JPS6341910B2 (en, 2012) 1988-08-19

Family

ID=25771134

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13559177A Granted JPS5363385A (en) 1976-11-12 1977-11-11 Novel aminopropanole derivative process for preparing same and medicine having vasodilating and betaaacceptor interupiing efect

Country Status (23)

Country Link
US (1) US4146630A (en, 2012)
JP (1) JPS5363385A (en, 2012)
AR (3) AR218643A1 (en, 2012)
AT (1) AT361476B (en, 2012)
AU (1) AU510284B2 (en, 2012)
CA (1) CA1086740A (en, 2012)
CH (3) CH636099A5 (en, 2012)
CS (1) CS228106B2 (en, 2012)
DD (1) DD133801A5 (en, 2012)
DK (1) DK500677A (en, 2012)
ES (2) ES472746A1 (en, 2012)
FI (1) FI62077C (en, 2012)
FR (1) FR2370744A1 (en, 2012)
GB (1) GB1541547A (en, 2012)
HU (1) HU177410B (en, 2012)
IL (1) IL53323A (en, 2012)
IT (1) IT1087490B (en, 2012)
LU (1) LU78498A1 (en, 2012)
NL (1) NL7712220A (en, 2012)
PL (2) PL110782B1 (en, 2012)
SE (1) SE7712720L (en, 2012)
SU (2) SU890975A3 (en, 2012)
YU (3) YU266477A (en, 2012)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314943A (en) * 1977-07-13 1982-02-09 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
US4495352A (en) * 1979-02-13 1985-01-22 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
DE2905876A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue piperidinopropylderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2922084A1 (de) * 1979-05-31 1980-12-11 Boehringer Mannheim Gmbh Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3200304A1 (de) * 1981-01-16 1982-08-26 Sandoz-Patent-GmbH, 7850 Lörrach 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
DE3584560D1 (de) * 1984-04-09 1991-12-05 Du Pont Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
US5614523A (en) * 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5789402A (en) * 1995-01-17 1998-08-04 Eli Lilly Company Compounds having effects on serotonin-related systems
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5627196A (en) * 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5741789A (en) 1995-01-17 1998-04-21 Eli Lilly And Company Compounds having effects on serotonin-related systems
ZA9610736B (en) 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
US8642583B2 (en) 2008-10-30 2014-02-04 Janssen Pharmaceutica Nv Serotonin receptor modulators
WO2010059390A1 (en) 2008-10-30 2010-05-27 Janssen Pharmaceutica Nv Modulators of serotonin receptor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB925429A (en) * 1960-04-01 1963-05-08 Irwin Neisler & Co Indole derivatives
US3699123A (en) * 1970-03-24 1972-10-17 Sandoz Ltd 4-(3-amino-2-hydroxy-propoxy) indole derivatives
BE794333A (fr) * 1972-01-20 1973-07-19 Wyeth John & Brother Ltd Composes heterocycliques azotes therapeutiques
JPS48103590A (en, 2012) * 1972-04-13 1973-12-25
JPS6024100B2 (ja) * 1975-02-11 1985-06-11 ベーリンガー・マンハイム・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング アミノプロパノ−ル−誘導体の製法
DE2549568C3 (de) * 1975-11-05 1981-10-29 Bayer Ag, 5090 Leverkusen 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel

Also Published As

Publication number Publication date
SU826955A3 (ru) 1981-04-30
PL110782B1 (en) 1980-07-31
IL53323A (en) 1981-12-31
AU3046677A (en) 1979-05-17
YU128983A (en) 1984-04-30
IL53323A0 (en) 1978-01-31
ES472747A1 (es) 1979-02-16
YU128883A (en) 1984-04-30
CH639086A5 (de) 1983-10-31
AR221081A1 (es) 1980-12-30
IT1087490B (it) 1985-06-04
CH643554A5 (de) 1984-06-15
HU177410B (en) 1981-10-28
SE7712720L (sv) 1978-05-13
FI62077B (fi) 1982-07-30
SU890975A3 (ru) 1981-12-15
ES472746A1 (es) 1979-02-16
CH636099A5 (de) 1983-05-13
LU78498A1 (en, 2012) 1979-02-02
CS228106B2 (en) 1984-05-14
CA1086740A (en) 1980-09-30
FI62077C (fi) 1982-11-10
JPS5363385A (en) 1978-06-06
DK500677A (da) 1978-05-13
ATA808277A (de) 1980-08-15
FR2370744B1 (en, 2012) 1981-06-12
DD133801A5 (de) 1979-01-24
AU510284B2 (en) 1980-06-19
NL7712220A (nl) 1978-05-17
AR218643A1 (es) 1980-06-30
FI773346A7 (fi) 1978-05-13
AR221868A1 (es) 1981-03-31
YU266477A (en) 1984-02-29
PL201997A1 (pl) 1979-03-12
FR2370744A1 (fr) 1978-06-09
US4146630A (en) 1979-03-27
PL112683B1 (en) 1980-10-31
AT361476B (de) 1981-03-10
GB1541547A (en) 1979-03-07

Similar Documents

Publication Publication Date Title
JPS6341910B2 (en, 2012)
JPH11512701A (ja) 選択的なβ▲下３▼アドレナリン作動性アゴニスト
JP2007528362A (ja) 置換アリールアルカン酸誘導体及びその用途
NO164476B (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,3,5-tetrahydroimidazo-(2,1-b)-kinazoliner.
NO313137B1 (no) Ftalazinoner
KR100911280B1 (ko) 아미노알킬벤조일-벤조푸란 또는 벤조티오펜 유도체, 그의제조방법 및 그를 포함하는 조성물
NO871879L (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive heterocykliske forbindelser.
CA2312987A1 (en) Selective .beta.3 adrenergic agonists
JPH0717635B2 (ja) ５−［１−（イミダゾール）メチル−３，３−ジ置換−２（３ｈ）フラノン誘導体
FI66370B (fi) Foerfarande foer framstaellning av nya farmakologiskt anvaendbara piperidinopropylderivat
KR20030023769A (ko) 아미노알콕시벤조일-벤조푸란 또는 벤조티오펜 유도체,그의 제조 방법 및 이를 포함하는 조성물
US4363808A (en) N-(3-Phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
US3687969A (en) 9-aroyl-1,2,3,4-tetrahydrocarbazole-3,3-dicarboxylic acids
JPS5953480A (ja) Ｔｘａ↓２抑制剤としてのピリジニル置換ベンズイミダゾ−ル類及びキノキサリン
NO124724B (en, 2012)
DE2737630A1 (de) Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS5845423B2 (ja) 新規アミノプロパノ−ル・誘導体の製法
JPS6139306B2 (en, 2012)
JPH0784439B2 (ja) ヒドロキシアルコキシ―４―フェニルプロピルインドールの新規な誘導体及びその塩、それらの製造方法並びに不整脈防止剤
JPS6212757A (ja) 桂皮酸アミド誘導体
JPS6345667B2 (en, 2012)
US4438116A (en) Quinoxalinyloxy-amino-propanol compounds with blood pressure lowering and β-blocking properties, their use and pharmaceutical compositions containing them
JPS62267269A (ja) ピラゾ−ル−３−アミン類
JPH02270868A (ja) 抗炎症性１―ヘテロアリール―３―アシル―２―オキシンドール類
CS228110B2 (en) Production of novel derivatives of 3-/4-phenoxymethylpi